OMX30 1 602 -0,1%  OMXH25 3 938 0,0%  OMXC20 1 023 -0,8%  Dow 22 296 -0,2%  Nas 5 867 -1,1%  EUR 9,5489 0,2%  USD 8,0699 0,3%  Olja 58,7 -0,7%  Guld 1 308 -0,2% 

Johnson & Johnson Aktie

131,21USD -0,12USD -0,09%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Johnson & Johnson Chart - 1 År - BTT

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,34 3,56 3,77 3,86
Direktavkastning (i %) 2,71 2,50 2,67 2,82 2,89
PE-tal 17,24 18,61 17,26 16,26 15,40
Resultat/aktie 6,73 7,18 7,74 8,22 8,68

Nyheter om Johnson & Johnson

ytterligare nyheter

Analyser om Johnson & Johnson

ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 52,60
0,2%
Alexion Pharmaceuticals 144,02
0,8%
Allergan 0,00
0,0%
AstraZeneca 539,00
-0,5%
Bayer 111,40
-0,4%
Beiersdorf 91,26
-0,5%
Celgene 144,96
0,7%
DOUGLAS 0,00
0,0%
Fresenius Medical Care 81,50
-0,6%
Fresenius 67,62
-0,7%
GlaxoSmithKline 14,74
-0,4%
Johnson & Johnson 131,21
-0,1%
Merck 65,16
0,0%
Merck 99,61
1,2%
MorphoSys 71,28
-0,6%
Nestlé 80,65
-0,6%
Novartis 83,55
-0,4%
Pfizer 35,52
-1,2%
Procter & Gamble 92,71
0,6%
Roche 248,10
-0,6%
STADA 80,95
-0,5%
Sanofi 84,14
-0,6%
Unilever 49,40
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnsontill bolagsprofilen

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Its baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. It include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid 131,17 USD Ask 131,23 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 131,21 USD -0,12 -0,09 %
Kurstid 21:59:59
Datum 25.09.2017
Öppning 131,40
Gårdagen 131,33
Dagshögsta 131,75
Dagslägsta 130,85
52 v. högsta 137,06
52 v. lägsta 109,33
52 v. perf.
Volym (Antal) 260 628
Börsvärde (SEK) 2 813,81 Mrd
Börsen
Kurs för 131,21 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 058,85 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index S&P 500, S&P 100, NYSE US 100, Dow Jones, BX Swiss - USA

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 813,81 Mrd
Free float % 99,90
Antal aktier mio. 2 684,00
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,43
60 dagar vola 13,55
PBV 4,23

Johnson & Johnson Historiska kurser

2017-09-25 131,21 260 628
2017-09-22 131,33 227 163
2017-09-21 131,77 260 815
2017-09-20 133,23 365 657
2017-09-19 135,30 208 266

Aktier i samma industri med bättre 1 års perf.

Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
Immunomedics Inc. 227,8 %
Merge Healthcare Inc Cash Settlement At USD 7.13 A Sh 219,3 %
Cutera Inc. 218,4 %